银屑病患者炎症小体活性增强促进系统性炎症
该研究探讨银屑病患者系统性炎症的细胞机制,发现患者血浆中炎症小体生成的IL-1β和IL-18水平升高,且与外周血细胞中NLRP3、NLRP1和AIM2高表达及髓系细胞caspase-1反应性增强相关。TNF-α通过TNFR-caspase-8-caspase-1替代途径选择性激活NLRP3炎症小体;抗TNF治疗可正常化血浆IL-1β、IL-18水平及caspase-1反应性,而甲氨蝶呤治疗则无此效应。
要点
- 银屑病患者血浆IL-1β和IL-18升高,且与皮损严重程度无关。
- TNF-α通过TNFR-caspase-8-caspase-1途径激活NLRP3炎症小体。
- 抗TNF治疗可正常化炎症小体功能,甲氨蝶呤则不能。
核心结论
- TNF-α介导的NLRP3炎症小体激活可能促进银屑病系统性炎症,抗TNF治疗可正常化炎症小体功能。
研究设计与样本
- 研究纳入银屑病患者,比较血浆炎症小体产物、外周血细胞炎症小体传感器表达及caspase-1反应性,并分析不同治疗对炎症小体功能的影响。
主要发现
- 银屑病患者血浆IL-1β和IL-18水平高于对照,且与皮肤病变严重程度无相关性。
- 患者外周血细胞中NLRP3、NLRP1和AIM2组成型表达增加,轻症患者亦如此,并伴有髓系血细胞亚群caspase-1反应性增强。
- TNF-α无需 priming 信号即可选择性激活NLRP3炎症小体,通过TNFR-caspase-8-caspase-1替代途径,不依赖细胞焦亡。
- 接受抗TNF治疗的患者血浆IL-1β、IL-18水平及caspase-1反应性均正常化,而甲氨蝶呤治疗患者caspase-1反应性持续增高。
临床怎么用
- 银屑病患者系统性炎症评估可关注炎症小体相关指标,抗TNF治疗可能通过抑制炎症小体降低心血管风险。
局限性
- 原文未明确报告样本量、对照设置及统计效能等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is linked to systemic inflammation and cardiovascular comorbidities, but studies of the underlying cellular mechanisms are lacking. The NLRP3 inflammasome is genetically associated with psoriasis, and its activation is increasingly linked with cardiovascular disease. In this study, we show that patients with psoriasis exhibited higher plasma levels of inflammasome-generated IL-1β and IL-18, without any correlation to skin lesion severity. Increased constitutive expression of the inflammasome sensors NLRP3, NLRP1, and AIM2 was found in peripheral blood cells of the patients and also of those with mild disease, and this was accompanied by an increased caspase-1 reactivity in the myeloid blood subsets. TNF-α was found to activate selectively the NLRP3 inflammasome without the requirement for a priming signal. TNF-α was found to signal through the TNFR‒caspase-8‒caspase-1 alternative inflammasome pathway, which proceeds independently of pyroptosis. Patients who received anti-TNF therapy had normalized plasma IL-1β and IL-18 levels as well as normalized caspase-1 reactivity. This was in contrast to the patients treated with methotrexate who exhibited persistent, increased caspase-1 reactivity. Thus, we show that the TNF-α-mediated activation of NLRP3 inflammasomes in patients with psoriasis may contribute to systemic inflammation. Anti-TNF therapy normalized inflammasome function, suggesting a mechanism for the cardiovascular risk‒reducing effect.
引用
- Verma D, Fekri SZ, Sigurdardottir G, et al. Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation. J Invest Dermatol. 2020. PMID: 32896537. doi:10.1016/j.jid.2020.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。